Pharmaceuticals · Market research

Alzheimer's Disease Drugs reports

Coverage across 33 countries and regions. Researched figures and forecasts come with the full report.

Get the full Alzheimer's Disease Drugs market evidence

The purchased report supplies researched market size, forecast, growth, segments, competition and sources.

Buy the full report Request free sample
Alzheimer's Disease Drugs reports by place
PlaceCurrent sizeForecastGrowthActive trialsReport
WorldIn full reportIn full reportIn full report941View report
AfricaIn full reportIn full reportIn full report1View report
APACIn full reportIn full reportIn full report193View report
AustraliaIn full reportIn full reportIn full report40View report
BrazilIn full reportIn full reportIn full report17View report
CanadaIn full reportIn full reportIn full report74View report
ChinaIn full reportIn full reportIn full report135View report
EcuadorIn full reportIn full reportIn full report0View report
EgyptIn full reportIn full reportIn full report1View report
EuropeIn full reportIn full reportIn full report226View report
FranceIn full reportIn full reportIn full report91View report
GermanyIn full reportIn full reportIn full report33View report
Hong KongIn full reportIn full reportIn full report7View report
IndiaIn full reportIn full reportIn full report5View report
ItalyIn full reportIn full reportIn full report65View report
JapanIn full reportIn full reportIn full report34View report
KenyaIn full reportIn full reportIn full report0View report
Latin AmericaIn full reportIn full reportIn full report20View report
MalaysiaIn full reportIn full reportIn full report1View report
MexicoIn full reportIn full reportIn full report8View report
Middle EastIn full reportIn full reportIn full report5View report
New ZealandIn full reportIn full reportIn full report4View report
North AmericaIn full reportIn full reportIn full report429View report
PhilippinesIn full reportIn full reportIn full report1View report
RussiaIn full reportIn full reportIn full report3View report
Saudi ArabiaIn full reportIn full reportIn full report2View report
SingaporeIn full reportIn full reportIn full report9View report
South AfricaIn full reportIn full reportIn full report0View report
SpainIn full reportIn full reportIn full report66View report
ThailandIn full reportIn full reportIn full report1View report
UAEIn full reportIn full reportIn full report2View report
UKIn full reportIn full reportIn full report57View report
USIn full reportIn full reportIn full report389View report

Public clinical research

941 active trials found worldwide on ClinicalTrials.gov.

See the public search

Latest public research

  1. Molecular Insights on the Reduction-Dependent Electronic Modulation of Graphene Oxide Surface Toward Reactivity and Acetylcholinesterase Inhibition of Alzheimer's Drugs.Chemphyschem : a European journal of chemical physics and physical chemistry, 2026
  2. Disproportionality analysis of adverse event signals associated with seven Alzheimer's drugs: insights from the FAERS database.Frontiers in pharmacology, 2026
  3. From mechanism to substratome: Unraveling mysteries of γ-secretase.The Journal of biological chemistry, 2026
  4. [Occurrence Characteristics and Associated Factors of Alzheimer's Disease Drugs in Wastewater in China].Huan jing ke xue= Huanjing kexue, 2026
  5. Patient and public involvement and engagement in clinical trials at scale: Analysis of the first 3250 responses on the POrtal for Patient and Public Engagement in Dementia (POPPED).Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026

Top Alzheimer's Disease Drugs companies and key players

Public trial and paper counts come from ClinicalTrials.gov and PubMed. Acuitas market figures are not published on this page.